Engel, H <br/><br/>
Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cells.  [electronic resource] 

 -  Leukemia  Apr 1999 
 - 568-77 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2401359  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anemia, Refractory, with Excess of Blasts--diagnosis<br/>Antigens, Differentiation--analysis<br/>Antigens, Neoplasm--analysis<br/>Cell Division<br/>Chromosome Aberrations<br/>Chromosomes, Human, Pair 7<br/>Clone Cells--chemistry<br/>Disease Progression<br/>Disease-Free Survival<br/>Female<br/>Flow Cytometry<br/>Hematopoietic Stem Cells--chemistry<br/>Humans<br/>Immunophenotyping<br/>In Situ Hybridization, Fluorescence<br/>Karyotyping<br/>Leukemia, Myeloid--classification<br/>Life Tables<br/>Male<br/>Middle Aged<br/>Monosomy<br/>Myelodysplastic Syndromes--classification<br/>Neoplasm, Residual<br/>Neoplastic Stem Cells--chemistry<br/>Proportional Hazards Models<br/>Recurrence